These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28383667)

  • 1. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.
    Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ
    Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
    Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 Promotes DNA Damage Response Bypass following Oxidative Stress in a Model of Hydrogen Peroxide-Associated Ulcerative Colitis through JNK Inactivation and Chromatin Binding.
    Reissig K; Silver A; Hartig R; Schinlauer A; Walluscheck D; Guenther T; Siedentopf S; Ross J; Vo DK; Roessner A; Poehlmann-Nitsche A
    Oxid Med Cell Longev; 2017; 2017():9303158. PubMed ID: 28751935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
    Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21.
    Lin K; Jiang H; Zhang LL; Jiang Y; Yang YX; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
    Dig Dis Sci; 2018 Sep; 63(9):2320-2331. PubMed ID: 29808247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
    van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
    Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
    Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated H2 O2 exposure drives cell cycle progression in an in vitro model of ulcerative colitis.
    Poehlmann A; Reissig K; Schönfeld P; Walluscheck D; Schinlauer A; Hartig R; Lessel W; Guenther T; Silver A; Roessner A
    J Cell Mol Med; 2013 Dec; 17(12):1619-31. PubMed ID: 24118792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer.
    Gerçeker E; Boyacıoglu SO; Kasap E; Baykan A; Yuceyar H; Yıldırım H; Ayhan S; Ellidokuz E; Korkmaz M
    Oncol Rep; 2015 Oct; 34(4):1905-14. PubMed ID: 26259750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
    Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.
    Gushima M; Hirahashi M; Matsumoto T; Fujita K; Ohuchida K; Oda Y; Yao T; Iida M; Tsuneyoshi M
    Histopathology; 2011 Sep; 59(3):460-9. PubMed ID: 22034886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.
    Ioachim EE; Katsanos KH; Michael MC; Tsianos EV; Agnantis NJ
    Int J Colorectal Dis; 2004 Jul; 19(4):325-33. PubMed ID: 15060836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
    Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of the Pleckstrin and Sec7 domain-containing gene is implicated in ulcerative colitis-associated carcinogenesis through its inhibitory effect on apoptosis.
    Okada S; Suzuki K; Takaharu K; Noda H; Kamiyama H; Maeda T; Saito M; Koizumi K; Miyaki Y; Konishi F
    Int J Oncol; 2012 Mar; 40(3):686-94. PubMed ID: 22002136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.